GO THERAPEUTICS
GO Therapeutics is the only company with the technologies, platforms and know-how to harness the power of the cancer glycoproteome to generate exceptionally tumor-specific antibodies for cancer immunotherapies. By making antibodies to hybrid antigens combining a tumorโs up-regulated protein expression with a proteinโs aberrant glycosylation pattern, we are able to dramatically increase tumor specificity. Our technology clears the hurdles for making drugs that are extremely specific to the cancer cell.
GO THERAPEUTICS
Social Links:
Industry:
Biotechnology Health Care Pharmaceutical
Founded:
2014-01-01
Address:
Cambridge, Massachusetts, United States
Country:
United States
Website Url:
http://www.gotherapeutics.com
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
5 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt Apple Mobile Web Clips Icon WordPress Content Delivery Network Font Awesome
Similar Organizations
Atlas Venture
Atlas Venture creates and invests in biotech startup companies with seed and early stage venture investments.
Aura Biosciences
Aura Biosciences is a biotechnology company that focuses on the development of drugs by using tumor targeted pseudovirions.
Geneos Therapeutics
Geneos Therapeutics is a developer of a neo-antigen based personalized immunotherapy designed to offer cancer treatment.
Idera Pharmaceuticals
Idera Pharmaceuticals is engaged in the discovery and development of novel synthetic DNA and RNA-based drug candidates.
ROME Therapeutics
ROME Therapeutics is developing novel therapies for cancer and autoimmune diseases by harnessing the power of the repeatome.
Current Advisors List
Current Employees Featured
Founder
Investors List
Shenzhen Salubris Pharmaceuticals
Shenzhen Salubris Pharmaceuticals investment in Funding Round - GO Therapeutics
Official Site Inspections
http://www.gotherapeutics.com
- Host name: 141.193.213.20
- IP address: 141.193.213.20
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "GO Therapeutics"
GO Therapeutics
Go for clean cancer targets Fueling the future of solid tumor therapies GOโs validated discovery platform finds the novel, super-clean targets โ and the antibodies against them โ needed to โฆSee details»
GO Therapeutics - Crunchbase Company Profile
GO Therapeutics is the only company with the technologies, platforms and know-how to harness the power of the cancer glycoproteome to generate โฆSee details»
GO Therapeutics - LinkedIn
GO Therapeutics | 1,030 followers on LinkedIn. Opening the Therapeutic Window for antibody-based cancer therapies | GO Therapeutics is exploiting unique aspects of cancer cell biology to develop a ...See details»
GO Therapeutics - Craft
GO Therapeutics has 5 employees across 2 locations and $5 m in total funding,. See insights on GO Therapeutics including office locations, competitors, revenue, financials, executives, โฆSee details»
GO Therapeutics Information - RocketReach
GO Therapeutics is a Biotechnology Research, Business Services General, and Biotechnology company located in Natick, Massachusetts with $4 million in revenue and 9 employees. Find โฆSee details»
Go Therapeutics - Company Profile - Tracxn
Aug 17, 2021 Go Therapeutics - Tumor-specific antibodies for cancer immunotherapy. Raised a total funding of $5M over 1 round from 1 investor.See details»
Using new advances in glycoproteomics, GO Therapeutics uses a โฆ
Using new advances in glycoproteomics, GO Therapeutics uses a platform-based cancer targets. Using new advances in glycoproteomics, GO Therapeutics uses a platform-based approach to โฆSee details»
GO Therapeutics - VentureRadar
Founded in 2014 "GO Therapeutics identifies sites of O-linked glycosylation on a wide range of proteins targets. The accessibility of these O-glycans at the plasma membrane is used to โฆSee details»
GO Therapeutics' Leadership Team - Team members and org chart โฆ
About The leadership team at GO Therapeutics has a long history of experience in the biotech industry. They have worked at companies such as Ohana Biosciences, UNITY Biotechnology, โฆSee details»
Go Therapeutics, Inc. - Drug pipelines, Patents, Clinical trials
Explore Go Therapeutics, Inc. with its drug pipeline, therapeutic area, technology platform, 5 news, Disease Domain:Neoplasms, Technology Platform:Antibody, Antibody ...See details»
GO Therapeutics - Work in biotech
GO Therapeutics is developing therapies against cancer by exploiting unique cancer cell targets. An ideal cancer therapeutic would be specific, potent and broad-spectrum, treating a variety of โฆSee details»
Go Therapeutics 2025 Company Profile: Valuation, Funding
Information on valuation, funding, cap tables, investors, and executives for Go Therapeutics. Use the PitchBook Platform to explore the full profile.See details»
GO Therapeutics Management Team | Org Chart - RocketReach
GO Therapeutics is exploiting unique aspects of cancer cell biology to develop a new class of cancer therapies for previously intractable solid tumors. We target O-linked glycoproteins โฆSee details»
GO Therapeutics - LifeScienceHistory.com
GO is advancing the promise of antibody-based therapeutics to solid tumors ๏พ a huge disease family that has proven largely resistant to the many emerging cell-based and immuno โฆSee details»
GO Therapeutics Company Overview, Contact Details
Aug 17, 2017 Learn more about GO Therapeutics's company details, contact information, competitors, and more. Find accurate contact data easily with LeadIQ. Book a demo today.See details»
Astellas and GO Therapeutics Enter into Strategic Research and โฆ
Jun 1, 2022 GO is applying new advances in glycoproteomics to develop antibody-based cancer therapeutics that specifically target cancer cells. Xyphos holds a novel and proprietary ACCEL โฆSee details»
GO Therapeutics - Overview, News & Similar companies - ZoomInfo
May 31, 2022 View GO Therapeutics (www.gotherapeutics.com) location in Massachusetts, United States , revenue, industry and description. Find related and similar companies as well โฆSee details»
Astellas taps GO's glycoprotein platform with $783.5m deal
Jun 1, 2022 Astellas has become the latest big pharma company to sink some money into immuno-oncology start-up GO Therapeutics, forging an alliance to develop antibodies โฆSee details»
Cambridge startup, GO Therapeutics make $195 million deal with โฆ
Oct 5, 2018 This agreement grants Roche exclusive license for antibodies generated against novel cancer-specific targets and to develop a new glycotargeting bispecific antibody. By โฆSee details»
WHO releases global action plan to strengthen clinical trial โฆ
2 days ago The World Health Organization (WHO) has published the Global action plan for clinical trial ecosystem strengthening (GAP-CTS), a key implementation tool aligned with โฆSee details»